In contrast, studies measuring IGFBP-3 protein levels in a series of human breast cancer tissues showed higher IGFBP-3 levels in ER-negative than in ER-positive tumors [11,23-26]. This evidence concerns the gene IGFBP3 and breast carcinoma.